These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1006 related items for PubMed ID: 18497466

  • 41. Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension.
    Díez J.
    Clin Ther; 2006 Jun; 28(6):832-48. PubMed ID: 16860167
    [Abstract] [Full Text] [Related]

  • 42. [Hypertension in the elderly].
    Plouin PF, Rossignol P, Bobrie G.
    Bull Acad Natl Med; 2006 Jun; 190(4-5):793-805; discussion 806, 873-6. PubMed ID: 17195607
    [Abstract] [Full Text] [Related]

  • 43. [Stress-associated hypertension in the work place: results of the STARLET project].
    Lüders S, Hammersen F, Kulschewski A, Frerichs A, Frieg R, Hahnheiser D, Reich G, Schnieders M, Schrandt G, Schrader J.
    Dtsch Med Wochenschr; 2006 Nov 17; 131(46):2580-5. PubMed ID: 17096303
    [Abstract] [Full Text] [Related]

  • 44. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE, Berge E, Bangalore S, Messerli FH, Mancia G, Holzhauer B, Hua TA, Zappe D, Zanchetti A, Weber MA, Julius S.
    Blood Press; 2016 Nov 17; 25(2):83-92. PubMed ID: 26511535
    [Abstract] [Full Text] [Related]

  • 45. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S, Messerli FH, Cohen JD, Bacher PH, Sleight P, Mancia G, Kowey P, Zhou Q, Champion A, Pepine CJ, INVEST Investigators.
    Am Heart J; 2008 Aug 17; 156(2):241-7. PubMed ID: 18657652
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A, Schmieder RE, Triposkiadis F, Wenzel RR, Laurent S, Kohlmann O, Fogari R, MORE Study Group.
    J Hypertens; 2008 Apr 17; 26(4):813-8. PubMed ID: 18327093
    [Abstract] [Full Text] [Related]

  • 48. Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study.
    Reims HM, Kjeldsen SE, Brady WE, Dahlöf B, Devereux RB, Julius S, Beevers G, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H.
    J Hum Hypertens; 2004 Jun 17; 18(6):381-9. PubMed ID: 15103313
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
    Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE.
    J Nephrol; 2008 Jun 17; 21(4):566-9. PubMed ID: 18651547
    [Abstract] [Full Text] [Related]

  • 52. [A 20-year prospective study on risk factors for myocardial infarction of 5,137 men in Capital Steel and Iron Company].
    Yue H, Gu DF, Wu XG, Yu XH, Duan XF, Wang JH, Zheng RP, Zhou J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jan 17; 38(1):43-6. PubMed ID: 14989905
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
    Olsen MH, Wachtell K, Ibsen H, Lindholm LH, Dahlöf B, Devereux RB, Kjeldsen SE, Oikarinen L, Okin PM, LIFE Study Investigators.
    J Hypertens; 2006 Apr 17; 24(4):775-81. PubMed ID: 16531808
    [Abstract] [Full Text] [Related]

  • 56. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A, Bashir K, Anwar E.
    Nepal Med Coll J; 2007 Jun 17; 9(2):79-83. PubMed ID: 17899953
    [Abstract] [Full Text] [Related]

  • 57. [Antihypertensive therapy in the elderly: results of large trials].
    Leonetti G, Cuspidi C, Facchini M.
    Ital Heart J Suppl; 2001 Nov 17; 2(11):1161-9. PubMed ID: 11775407
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Hypertension as a function of age].
    Gensini GF, Corradi F.
    Ital Heart J; 2000 Jun 17; 1 Suppl 2():23-31. PubMed ID: 10905125
    [Abstract] [Full Text] [Related]

  • 60. The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
    Fossum E, Moan A, Kjeldsen SE, Devereux RB, Julius S, Snapinn SM, Edelman JM, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Dahlöf B, LIFE Study Group.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):770-5. PubMed ID: 16139123
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.